#Drug delivery1

New inhaled nanoparticle treatment for tuberculosis

Researchers at the University at Buffalo developed inhalable nanoparticles that carry rifampin to lung immune cells. In mice the treatment kept drug levels in the lung much longer and may allow weekly dosing with fewer side effects.

Photo by National Institute of Allergy and Infectious Diseases, Unsplash